Nyxoah to Host Investor Day on July 8 in New York Featuring Genio
Medical technology company Nyxoah will host an Investor Day on Wednesday, July 8 in New York, focusing on its growth strategy. The leadership and board will detail the commercial execution of its Genio system in the American market, as well as key steps towards profitability.
A Half-Day Event Focused on Three Strategic Pillars
Nyxoah will hold its Investor and Analyst Day on Wednesday, July 8, 2026, from 10:00 AM to 12:30 PM (New York time) at the Bank of America offices in Manhattan. The event will be broadcast live for remote participants, with a recording available afterward. Investors and analysts joining via webcast will be able to ask questions in real time. The agenda will cover three areas: the commercial dynamics of Genio in the U.S., including key performance indicators for the second quarter; the reimbursement outlook in the American landscape, presented in partnership with JD Lymon Group, an independent firm specializing in market access and reimbursement; and the path to profitability, outlining the company's framework for disciplined growth and capital efficiency.
Participation Including Leadership, Board, and External Experts
Robert Taub, chairman of the board, and Olivier Taelman, CEO, will participate along with the executive team. The event will also bring together two sleep specialists (Andrew T. Huang and Vikas Jain) as well as JD Lymon Group to provide a clinical and market perspective on obstructive sleep apnea and its reimbursement ecosystem in the U.S. Participants can register via Nyxoah's investor site or by contacting IR@nyxoah.com to access the webcast.
